SAN DIEGO -- iXCells Biotechnologies ("iXCells" or the "Company"), a high growth provider of cell-based products and discovery services to the academic, biotech and pharmaceutical communities worldwide, with special focus on primary and induced pluripotent stem cell ("iPSC") derived cellular models, today announced receiving a growth investment from Connecticut-based Great Point Partners ("GPP"), a private [...]

The agreement will deliver renewable energy equal to half of the company’s U.S. electricity consumption WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, recently signed an eight-year virtual power purchasing agreement with Enel North America to deliver a 90-megawatt (MW) portion of the Seven Cowboy wind project in [...]

The expansion is part of the company’s growth strategy for North America and will foster collaboration with life science companies and academia An inauguration event will take place on October 12, featuring presentations from collaborators at NeoGenomics, Takeda and Kymera ZURICH and CAMBRIDGE, Mass. Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, [...]

NEW LONDON, NH – US Customs Border & Protection Agency has evaluated and selected the LightLab 3 Cannabis Analyzer from Orange Photonics as its field-deployable cannabis testing solution. “Previous to this award, the U.S. Customs and Border Protection’s Laboratories and Scientific Services conducted a multi-phase assessment of LightLab 3 Cannabis Analyzer,” says Orange Photonics’ President, [...]

Leading genomic solutions provider launches NGS sample prep kits for researchers interested in identifying novel monkeypox variants through simple, viral surveillance solutions Molecular Loop Monkeypox Research panels now available for large-scale viral surveillance Simple 4-step, single-tube workflow, with 7800+ probes targeting the full genome WOBURN, Mass. -- Molecular Loop Biosciences, Inc., announced today that it has launched [...]

P4 Enhances their NGS capabilities to offer Precision Medicine to their patients INDIANAPOLIS -- P4 Diagnostix®, a network of nationally recognized laboratories ("P4"), will be partnering with Pierian, a global leader in advanced clinical genomics technology and services, to launch somatic testing for prostate cancer patients. Using the Illumina TruSight Oncology 500 cancer panel, P4 and [...]

RIYADH, Kingdom of Saudi Arabia -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics programs. The integration aligns with Saudi Arabia’s Vision 2030 to strengthen the Kingdom’s healthcare sector and its services with technological advancements. KFSH&RC is a leading [...]

GARDENA, CA -- Spectrum Chemical Mfg. Corp, (“Spectrum Chemical”), a leading global provider of fine chemicals, laboratory equipment and supplies, today announced the promotion of Russell Kneipp to President and Chief Executive Officer (CEO), effective immediately. Since 2018, Kneipp has served as Chief Operating Officer (COO) for Spectrum Chemical, where he instituted lean methodology and [...]

GOTTINGEN, Germany -- The life science group Sartorius today announced at the BioProcess International 2022 conference the launch of Sartobind ® Rapid A, a ready-to-use, disposable membrane for monoclonal antibody (mAb) capture. Biopharmaceutical partners who use packed bed chromatography for mAb capture typically suffer from ​low productivity, higher costs, and laborious operations​. Sartorius’ membrane will [...]

Vertex Pharmaceuticals will continue to use MaxCyte's Flow Electroporation® technology and ExPERT™ platform to support gene-edited cell therapy exa-cel, formerly known as CTX001™ for hemoglobinopathies ROCKVILLE, MD -MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today [...]